KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Align Technology (ALGN) EBITDA (2016 - 2025)

Historic EBITDA for Align Technology (ALGN) over the last 17 years, with Q3 2025 value amounting to $96.3 million.

  • Align Technology's EBITDA fell 4066.59% to $96.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.6 million, marking a year-over-year decrease of 1581.74%. This contributed to the annual value of $607.6 million for FY2024, which is 555.07% down from last year.
  • Align Technology's EBITDA amounted to $96.3 million in Q3 2025, which was down 4066.59% from $163.0 million recorded in Q2 2025.
  • Align Technology's 5-year EBITDA high stood at $268.9 million for Q2 2021, and its period low was $96.3 million during Q3 2025.
  • For the 5-year period, Align Technology's EBITDA averaged around $171.6 million, with its median value being $163.0 million (2025).
  • In the last 5 years, Align Technology's EBITDA surged by 46835.89% in 2021 and then tumbled by 4899.72% in 2022.
  • Quarter analysis of 5 years shows Align Technology's EBITDA stood at $220.9 million in 2021, then tumbled by 49.0% to $112.7 million in 2022, then soared by 52.27% to $171.5 million in 2023, then decreased by 15.97% to $144.1 million in 2024, then crashed by 33.2% to $96.3 million in 2025.
  • Its last three reported values are $96.3 million in Q3 2025, $163.0 million for Q2 2025, and $131.1 million during Q1 2025.